GlassScriptPhysician profile
Wesley Mcilwain
NPI 1477973220
$3,873.50
in general payments reported to CMS, 2019-2025
10 companies · $203 in 2025
The $203 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $96.50 · 2022: $84.77 · 2023: $3,059 · 2024: $430 · 2025: $203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,037 · Food and Beverage: $625 · Education: $30.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,036.96 |
| Food and Beverage | $625.27 |
| Education | $30.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $3,040.96 | 2023 | Inspire |
| Stryker Corporation | $273.85 | 2024-2025 | Na, Smartlock |
| Depuy Synthes Sales INC. | $156.41 | 2023-2024 | Matrixmandible, Matrixcombo, Matrixmidface |
| Polymedics Innovations INC. | $105.57 | 2024-2025 | |
| Intersect Ent, INC. | $96.50 | 2019 | |
| Karl Storz Endoscopy-America | $84.77 | 2022 | |
| Axogen | $33.50 | 2025 | |
| Surgenex LLC | $31.54 | 2025 | Surgraft, Ardeograft, Surmatrix |
| Smith+Nephew, INC. | $30.00 | 2024 | |
| Checkpoint Surgical, INC | $20.40 | 2025 | Checkpoint Stimulators |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wesley Mcilwain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.